Endoscopic Management of Primary Sclerosing Cholangitis

Initial Treatment Approach

The European Society of Gastrointestinal Endoscopy recommends balloon dilation alone as the first-line endoscopic treatment for dominant strictures in Primary Sclerosing Cholangitis (PSC), with short-term stenting reserved for strictures that fail to respond adequately to balloon dilation 1, 2

The American Gastroenterological Association suggests performing MRCP or contrast CT and reviewing with a hepatopancreaticobiliary multidisciplinary team before high-risk interventions, and conducting biliary brush cytology at ERCP with a sensitivity of 43% and specificity of 97% for cholangiocarcinoma 3, 2
The European Society of Gastrointestinal Endoscopy recommends considering cholangioscopy with direct visualization if available, with a sensitivity of 50-62% in PSC 3, 4

The American College of Gastroenterology strongly recommends administering prophylactic antibiotics before every ERCP in PSC patients due to the high risk of cholangitis 3, 2

The American Society for Gastrointestinal Endoscopy suggests selecting a balloon diameter up to 6-8 mm for hepatic ducts and up to 8 mm for the common bile duct, matching the caliber of ducts delimiting the stricture, and performing stepwise dilation to avoid exceeding upstream/downstream duct diameter 1, 2
The European Society of Gastrointestinal Endoscopy recommends repeating dilations at 1-4 week intervals until technical success, typically requiring 2-3 sessions, with technical success defined as complete balloon inflation with no waist on fluoroscopy plus unobstructed contrast passage to the duodenum 1, 2

The American Gastroenterological Association notes that balloon dilation has a superior safety profile compared to stenting, with a bile duct perforation rate of 0.2% of procedures versus 3.5% with aggressive dilation, and overall complications of 15% versus 54% with stenting 1, 4, 2

The European Society of Gastrointestinal Endoscopy recommends reserving stenting only for strictures refractory to balloon dilation alone, with a single 10-Fr stent for extrahepatic dominant strictures and two 7-Fr stents for hilar strictures extending into left or right hepatic duct 1, 2
The American College of Gastroenterology suggests removing stents after 1-2 weeks, with short-term stenting showing similar efficacy to standard 8-12 week stenting but with lower complication rates 1, 4, 2

The American Gastroenterological Association recommends regular endoscopic follow-up at 3, 6, 12, 18, and 24 months, then yearly, with repeat dilation for relapsing dominant strictures if the stricture causes recurrent symptoms or significant cholestasis increase, and previous dilations showed satisfactory response 1, 4